Participants in the double-blind study were randomly placed in one of two groups — one group used both an active nicotine patch and a nicotine inhaler while the other group used an active nicotine patch and a placebo inhaler. Both groups were instructed to use the inhalers for six months.
One month after the study completed, 31.71 percent of the smokers who used a nicotine inhaler had quit smoking, compared to 17.97 percent in the group who used a placebo inhaler.
“Currently most smokers use nicotine patches to help them stop smoking. This study shows that if you add a nicotine inhaler to a nicotine patch, it doubles the chances of quitting over a nicotine patch alone,” said co-author Julian Crane, MBBS.
More articles on smoking:
California bumps smoking age from 18 to 21
FDA announces new e-cigarette regulations: 6 things to know
Medicaid programs come up short in helping smokers quit, study finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
